Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-286209
Filing Date
2025-11-18
Accepted
2025-11-18 16:24:33
Documents
15
Effectiveness Date
2025-11-18

Document Format Files

Seq Description Document Type Size
1 S-8 d813559ds8.htm S-8 58822
2 EX-5.1 d813559dex51.htm EX-5.1 77509
3 EX-23.1 d813559dex231.htm EX-23.1 3275
4 EX-FILING FEES d813559dexfilingfees.htm   iXBRL EX-FILING FEES 20846
5 GRAPHIC g813559g1118074610361.jpg GRAPHIC 2529
  Complete submission text file 0001193125-25-286209.txt   302464

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT d813559dexfilingfees_htm.xml XML 11251
Mailing Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP
Business Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-291621 | Film No.: 251495083
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)